Varia Ventures

Exciting breakthrough in treatment! 🧠

, Inc. announces receipt of significant funding for , a game-changing vaccine.

SurVaxM's Phase 2b trials are set to transform the treatment landscape for this . With promising results already in hand, this investment marks a hopeful step forward for patients and caregivers.

Read More: https://ow.ly/FTfp50QpJvH

MimiVax Announces New Investments to Support Clinical Development of SurVaxM in Glioblastoma /PRNewswire/ -- MimiVax, Inc., a biotechnology company focused on the development of SurVaxM, a survivin-targeted vaccine therapy for glioblastoma and other...

📢 Big News in Battery Tech! 🌍💡

is revolutionizing the EV battery industry by setting up its first manufacturing plant in Lauenförde, Germany.

Their innovative silicon anodes, a leap from traditional graphite, plan to reduce reliance on Chinese materials, boosting energy density and slashing charge times.

A strategic move that marks a shift in the global battery landscape!

Read more: https://www.wsj.com/articles/u-s-battery-producer-enticed-to-set-up-shop-in-the-eu-dd92c539

WSJ News Exclusive | U.S. Battery Producer Enticed to Set Up Shop in the EU GDI’s silicon anodes can help cut reliance on Chinese materials, but the startup plans to build its first factory in Germany with EU funding.

Exciting news from EndoSound, Inc. on the FDA 510(k) clearance of the EndoSound Vision System® (EVS®).

This novel and innovative device enables to convert upper endoscopes into an endoscopic ultrasound (EUS) device.

🔗

EndoSound Receives 510(k) Clearance for Breakthrough EVS Innovation, a novel Endoscopic Ultrasound (EUS) technology – Endosound EndoSound Receives 510(k) Clearance for Breakthrough EVS Innovation, a novel Endoscopic Ultrasound (EUS) technologyCompany News, Industry News 510(k) Clearance of first-of-kind Endoscopic Ultrasound (EUS) technology Paves the way for safer and more accessible medical care EndoSound will begin its co...

We've extended the deadline on the 2024 SAGES -- The Society of American Gastrointestinal and Endoscopic Surgeons Shark Tank applications!

We have simplified the application process, and encourage anyone with a groundbreaking business model in the space to apply by Friday, December 22nd! 📅

This is your final call to apply and get the opportunity to present at the annual meeting, competing for the grand prize of $30,000, and the opportunity for potential investment. 🌟

📍 Selected semi-finalists will take the stage at the NBT Innovation Weekend on February 23, 2024, in Houston.

🔗 Your idea could be the next big thing. Apply now: https://www.sages2024.org/shark-tank-2024/

Interesting article featuring one of our portfolio companies, , on their continued breakthroughs in battery technology! 👇

Learn more: https://electricdrives.tv/gdis-silicon-anode-the-fast-charging-high-energy-battery-breakthrough/

GDI's silicon anode: The fast-charging, high-energy battery breakthrough GDI's 100% silicon anode revolutionizes batteries with over 30% higher energy density and a rapid 15-minute charge. Safety is prioritized...

Varia is pleased to partner with SAGES -- The Society of American Gastrointestinal and Endoscopic Surgeons again this year to help support its annual Shark Tank Competition!

Meet last year's winner--AssistIQ! 🏆

AssistIQ's platform reduces supply waste and costs while minimizing the carbon footprint – without adding extra work for hospital administration.

Developed in a major hospital, the company's technology aims to enhance efficiency while easing nurses' administrative burden.

Lisa Israelovitch, Co-Founder & CEO of AssistIQ, shares, "Winning the prestigious SAGES Shark Tank prize helped us reach and engage in deeper conversations with numerous health systems. Since then, we’ve implemented AssistIQ's AI medical supply and intelligence platform with new partners. Collaborating with surgeons, nurses, perioperative, and supply chain teams, we've fine-tuned AssistIQ's platform for unparalleled accuracy in data capture and actionable preference card insights that meaningfully reduce costs and our carbon footprint."

Could YOU be next? 🚀

If you've got a groundbreaking idea in and a robust business model, apply for the competition and compete to win $30,000 plus a potential investment from the SINC Fund.

⏰ Act fast - applications close on Dec 19, 2023!

We're excited to see the semi-finalists in Houston on Feb 23, 2024!

🔗 Apply now: https://ow.ly/AT9A50Qgbhw

For more information or to apply via email, contact Julie at [email protected].

📸 Pictured: SAGES' Dr. Christopher Schlachta and Dr. Steven Schwaitzberg with Lisa Israelovitch, Co-Founder & CEO, AssistIQ

Varia is pleased to partner with SAGES -- The Society of American Gastrointestinal and Endoscopic Surgeons again this year to help support its annual Shark Tank Competition! Meet SAGES' 2022 Shark Tank Winner--Santanello Surgical's !

Vampiro is a pioneering dual lumen suction sleeve revolutionizing surgery. The device targets key infection risks by enhancing suction efficiency in complex cases, offering a breakthrough in patient care and cost savings.

With its innovative design, Vampiro addresses the limitations of single lumen spot suction catheters, providing enhanced suctioning capabilities and preventing occlusions. This breakthrough is particularly crucial in complex cases like peritoneal contamination or bowel perforations.

Vampiro's impact goes beyond efficiency – it's about cost savings too, aiming to reduce the hefty price tag of surgical infections in the US.

Ready to showcase your innovation? 🚀

Apply now for Shark Tank and be the change in healthcare! You can also email Julie at [email protected] for more information.

Hurry, applications close Dec 19, 2023!

Apply here: https://sages2024.org/shark-tank-2024

Dive into the 2024 SAGES -- The Society of American Gastrointestinal and Endoscopic Surgeons Shark Tank competition!

Got an innovative idea and a solid business model in ?

Apply now for your chance to present at the annual meeting and compete for the $30,000 first prize. The winner will also be considered for investment by the newly launched SINC Fund. 🌟

📅 Applications are now OPEN and close on December 19, 2023.

📍 Semi-finalists will present at the NBT Innovation Weekend on February 23, 2024, in Houston.

🔗 Click here to apply: https://www.sages2024.org/shark-tank-2024/

❇️ We're pleased to share an exciting development in Viridi Parente! ❇️

Viridi has launched its global operations with a new subsidiary in Saudi Arabia, and hired its President, a regional energy industry leader who previously served as Chief Engineer at Saudi Aramco.

More information 🔗 https://ow.ly/Lf7f50Q3eHT

Viridi Expands Global Presence with Launch of MENA Subsidiary Viridi, a developer of innovative battery technology that can be safely installed and operated in nearly any environment or location, is expanding its

GDI recently received national press on its silicone anode technology and its increasing importance in the lithium-ion battery market.

Read more ➡️ https://ow.ly/7igG50Q3eaP

Analysis: China's graphite curbs will accelerate plans around alternatives China's move on Friday to curb exports of graphite, a key electric vehicle battery material, will only accelerate efforts to develop alternative sources and materials, but that will take time, industry executives and analysts said.

🎉 Exciting News! We are pleased to announce the closing of our investment in Hubly Surgical!

Hubly has secured FDA Clearance for the Hubly Drill, "a groundbreaking and patented device poised to revolutionize bedside ." 🚀

Read more here: https://ow.ly/fq7X50PzqkV

🌱 Viridi, one of our portfolio companies and a cleantech firm in Buffalo, is transforming an abandoned industrial site into a symbol of hope and revitalization.

Viridi's presence in Buffalo provides employment opportunities and brings optimism to the "rust belt" community, which was hit hard by deindustrialization.

Their success showcases the positive impact of sustainable innovation and government support.

Read more:

The new era of big government: Biden rewrites the rules of economic policy Forty years after Reaganomics rejected government intervention in the economy, the US is embracing massive subsidies. But will voters notice?

One of our portfolio companies, Cleana Inc. is yet again making news! This time, they're featured on ABC News Boston! 🎉

The conversation provided a glimpse into the innovation behind their commercial and residential toilet seats, and their goals for advancing hygiene and sanitation.

Watch the full interview here: https://lnkd.in/eBK7vPBE

Cleana - ABC Channel 5 Boston Cleana developed special toilet seats meant to improve restroom cleanliness in both commercial and residential settings. We came together to create Cleana an...

We're pleased to announce the American Gastroenterological Association (AGA) Fund’s recent investment in Oshi Health, an innovative digestive health care experience that transforms access to care, the patient experience, clinical outcomes and healthcare economics!

In a high-touch virtual care delivery model, Oshi Health provides diagnosis and integrated care for digestive conditions and empowers people to achieve lasting control of their symptoms. More information about the company can be found in the link below press release.

🔗 https://tinyurl.com/ersyvy5z

The Fund invested approximately $90,000 in the company’s $30 million Series B financing, which was led by Koch Disruptive Technologies, and joined by existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures. This funding will be used to bolster the company’s market leadership and momentum, including accelerated contracting with payers and employers to reimburse access to Oshi Health as a covered benefit.

This marks the fifth investment by the Fund – which has also invested in Virgo, Endosound, NeXtGen Biologics and EvoEndo.

American College of Gastroenterology and American Gastroenterological Association Invest in Oshi Health to Accelerate Adoption of Hybrid Digestive Health Care Strategic investments mark novel endorsement of whole-person multidisciplinary hybrid care model for digestive health by two premier GI medical...

Proud to share that one of our portfolio companies, Cleana Inc., has been featured on the front page of The Boston Globe! 👏 👏 👏

Read the full article here: https://ow.ly/pGIR50OUlwK

With new toilet seat, BU and MIT engineers want to nip bathroom mishaps in the bud - The Boston Globe Cleana has developed a new kind of toilet seat that raises or lowers itself to avoid unwelcome splashes, or to prevent objects from falling accidentally into the bowl.

Congratulations to the team at MimiVax, LLC!

Check out this NBC News feature on ! Early results from an experimental vaccine for , the most deadly type of , show the potential to double patients' life expectancy and delay recurrence.

🎥: https://www.nbcnews.com/nightly-news/video/new-results-show-vaccine-could-help-fight-brain-cancer-182263877549

Roswell Park Comprehensive Cancer Center

New results show vaccine could help fight brain cancer Early results from an experimental vaccine for glioblastoma, a type of brain cancer, show the potential to delay recurrence and double life expectancy in patients. NBC News’ Anne Thompson speaks with a neurosurgeon, scientist and patient about the findings' potential impact.

Another exciting Viridi article! 🌿🔋

https://www.wkbw.com/news/wny-development/battery-manufacturer-energizes-former-east-buffalo-plant

Battery manufacturer energizes former east Buffalo plant The federal government is being asked to make a major investment in a facility in East Buffalo. U.S. Senator Charles Schumer wants to give millions of dollars to a growing battery manufacturer.

📣 BIG NEWS: Viridi, a cutting-edge system manufacturer in , is moving forward with its plans to add hundreds of jobs with the support of a $202m loan from the Department of Energy that has received the support of Senator Chuck Schumer and other notable political leaders.

Learn more: https://bit.ly/42fLnwA

We are thrilled to announce that the GI Opprtunity Fund with American Gastroenterological Association (AGA) has invested in EvoEndo, Inc., a medical device company developing platforms for Unsedated Transnasal Endoscopy.

“Expanding our fund’s portfolio to include technologies that can transform the pediatric GI landscape is particularly exciting for Varia Ventures.” - Andrea Vossler, co-founder and managing director at Varia.

Learn more! 👉🏼http://ow.ly/Mwwb50NJIqs

EvoEndo Announces Investment from AGA’s GI Opportunity Fund DENVER, April 13, 2023--EvoEndo has received investment from the American Gastroenterological Association's (AGA) new venture capital GI Opportunity Fund

VERY interesting article from our portfolio company, Viridi! Check it out!👇

What a great article on the partnership between one of our portfolio companies, Viridi, and National Grid US!

⚡️ https://bit.ly/3Koik37 ⚡

"The new era of storage has begun... The potential is almost limitless.️"

We're thrilled to share this news!

Recently, one of our portfolio companies, , announced that their product, , is showing positive results in patients with newly diagnosed .

Read more about the phase 2a study being conducted at Roswell Park Comprehensive Cancer Center: https://bit.ly/42zoXXF

📣 Sharing some exciting news!

announces that their first product, the fluorescence-guided Gastric Calibration Tube, has just received FDA 510(k) clearance! This technology uses near infrared ( ) light to allow to more clearly visualize tools inside the stomach.

Additionally, this is the first-ever device to gain authorization under the FDA's since its inception in 2021. So thrilled to hear this news!

Learn more here: https://www.pr.com/press-release/881320

🚨UPDATE: Viridi selects Bright Machines to digitally transform its manufacturing facility to meet the U.S. electric battery demand.

Read more here ➡️ https://bwnews.pr/3RbpGc6

Viridi Parente Selects Bright Machines to Digitally Transform Manufacturing Facility to Meet U.S. Electric Battery Demand Bright Machines, an innovator in intelligent, software-defined manufacturing, and Viridi Parente, Inc. (Viridi), a leader in developing safe, resilien

We're excited to share that American Gastroenterological Association (AGA)'s GI Opportunity Fund 1 has invested in EndoSound, Inc. an Oregon-based medical device innovator developing technologies that enhance access, reduce cost, and increase the safety of ultrasound ( ) procedures.

Read more ➡️ https://bwnews.pr/3wyy38m

Manmeet Singh Ahluwalia, MD, chief, Tumor Medical Oncology, Miami Cancer Institute [tag], discusses the evaluation of MimiVax’s in patients with newly diagnosed .

Dr. Ahluwalia confirms that this phase II trial saw improved patient outcomes, and “represents a promising therapy for newly diagnosed glioblastoma.”

Read more ➡️

Dr. Ahluwalia on the Evaluation of SurVaxM With Temozolomide in Newly Diagnosed Glioblastoma Manmeet Singh Ahluwalia, MD, discusses the evaluation of SurVaxM in combination with oral temozolomide in patients with newly diagnosed glioblastoma.

Great news for Viridi! Fresh off a nearly $95 million funding raise, has ramped up growth this year - and doesn’t plan to slow down.

Read more 👉 https://bit.ly/3YrCjTP

We’re proud to announce that has published a Phase IIa study of SurVaxM, a vaccine, in newly diagnosed in the Journal of Clinical Oncology.

Read the publication here: https://lnkd.in/eN4PvAzS

We’re proud to announce our collaboration with AllianceBernstein (AB)! Bernstein serves as confidants to some of the world’s most astute . With innovative , sophisticated modeling, and cutting-edge solutions, they’ll guide you and your community to achieve a more meaningful future. Bernstein is providing our investors with valuable educational resources.